These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 31826533)

  • 1. [Clinical characteristics and drug susceptibility test of nontuberculous mycobacterial lung disease].
    Lou H; Sun Q; Gu J; Yang H; Hao XH; Xiao HP; Sha W
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Dec; 42(12):901-906. PubMed ID: 31826533
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
    Litvinov V; Makarova M; Galkina K; Khachaturiants E; Krasnova M; Guntupova L; Safonova S
    PLoS One; 2018; 13(9):e0203108. PubMed ID: 30222736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Distribution and drug resistance of nontuberculous
    Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817
    [No Abstract]   [Full Text] [Related]  

  • 4. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
    Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y
    Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of time for diagnosis of nontuberculous mycobacterial lung disease and its associated factors in a tuberculosis-designated hospital in Shanghai].
    Zheng XB; He YF; Wang L; Sun Q; Shen XN; Wu XC; Yang JH; Yao L; Cui HY; Xu B; Yu FY; Sha W
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):380-387. PubMed ID: 36990702
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
    Shitrit D; Baum GL; Priess R; Lavy A; Shitrit AB; Raz M; Shlomi D; Daniele B; Kramer MR
    Chest; 2006 Mar; 129(3):771-6. PubMed ID: 16537880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of patients with non-tuberculous mycobacterial pulmonary disease: a seven-year follow-up study conducted in a certain tertiary hospital in Beijing.
    Liu Q; Du J; An H; Li X; Guo D; Li J; Gong W; Liang J
    Front Cell Infect Microbiol; 2023; 13():1205225. PubMed ID: 37424783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of slowly growing mycobacteria.
    Philley JV; Griffith DE
    Clin Chest Med; 2015 Mar; 36(1):79-90. PubMed ID: 25676521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and radiological features of Mycobacterium kansasii and other NTM infections.
    Matveychuk A; Fuks L; Priess R; Hahim I; Shitrit D
    Respir Med; 2012 Oct; 106(10):1472-7. PubMed ID: 22850110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China.
    Zhang Z; Pang Y; Wang Y; Cohen C; Zhao Y; Liu C
    Int J Antimicrob Agents; 2015 May; 45(5):491-5. PubMed ID: 25795316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease.
    Park S; Jo KW; Lee SD; Kim WS; Shim TS
    Respir Med; 2017 Dec; 133():36-41. PubMed ID: 29173447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.
    Kwon YS; Daley CL; Koh WJ
    Expert Rev Respir Med; 2019 Sep; 13(9):851-861. PubMed ID: 31256694
    [No Abstract]   [Full Text] [Related]  

  • 13. [Frequently Isolated Slow Growing Nontuberculous Mycobacteria from Pulmonary Samples and Evaluation of Drug Susceptibility Testing Results in a Referral Hospital in Turkey].
    Ceyhan İ; Özkara Ş; Güler MZ; Dulkar G; Altınsoy R; Vezir S
    Mikrobiyol Bul; 2019 Jul; 53(3):330-335. PubMed ID: 31414634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portuguese in vitro antibiotic susceptibilities favor current nontuberculous mycobacteria treatment guidelines.
    Durão V; Silva A; Macedo R; Durão P; Santos-Silva A; Duarte R
    Pulmonology; 2019; 25(3):162-167. PubMed ID: 30309821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.
    Gitti Z; Mantadakis E; Maraki S; Samonis G
    Future Microbiol; 2011 Sep; 6(9):1099-109. PubMed ID: 21958147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China.
    Wang MS; Wang JL; Wang XF
    BMC Pulm Med; 2016 Nov; 16(1):163. PubMed ID: 27887611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance and pathogenic spectrum of patients coinfected with nontuberculous mycobacteria and human-immunodeficiency virus in Chengdu, China.
    Wang DM; Liao Y; Li QF; Zhu M; Wu GH; Xu YH; Zhong J; Luo J; Li YJ
    Chin Med J (Engl); 2019 Jun; 132(11):1293-1297. PubMed ID: 30925547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013-2016.
    Tan Y; Su B; Shu W; Cai X; Kuang S; Kuang H; Liu J; Pang Y
    BMC Pulm Med; 2018 Nov; 18(1):168. PubMed ID: 30413193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lung diseases due to opportunistic environmental Mycobacteria in patients uninfected with human immunodeficiency virus. Risk factors, clinical and diagnostic aspects and course].
    Martínez Moragón E; Menéndez R; Santos M; Lorente R; Marco V
    Arch Bronconeumol; 1996 Apr; 32(4):170-5. PubMed ID: 8689013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, Clinical Manifestation, Treatment Outcome, and Drug Susceptibility Pattern of Nontuberculous Mycobacteria in HIV Patients in Tehran, Iran.
    Feysia SG; Hasan-Nejad M; Amini S; Hamzelou G; Kazemian H; Kardan-Yamchi J; Karami-Zarandi M; Feizabadi MM
    Ethiop J Health Sci; 2020 Jan; 30(1):75-84. PubMed ID: 32116435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.